Dr. James F. Barter, MD

Dr. Barter practices at Maryland Oncology Hematology, P.A. in Silver Spring, Maryland.

Dr. Barter's NPI, 1871622936, was assigned on March 5, 2007. Dr. Barter graduated from UVA School of Medicine in 1977. Dr. Barter holds Maryland license D0032793.

Dr. Barter's primary practice is Maryland Oncology Hematology, P.A., at 11886 Healing Way, Silver Spring, MD 20904 in Montgomery County. The practice phone is (301) 470-1001.

Dr. Barter's primary practice is Maryland Oncology Hematology, P.A. in Silver Spring, Maryland. The medical group on file is Maryland Oncology Hematology. Dmand AI also links Dr. Barter to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barter practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Barter's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Barter is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Barter's licenses on file in 5 states: Maryland, Virginia, District of Columbia, North Carolina and Alabama.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Barter treats.

CMS data shows 183 Medicare services from Dr. Barter across 5 procedure codes in 2024, for 106 Medicare patients. Medicare paid $20,550 for them.

CMS counts 106 Medicare patients who saw Dr. Barter in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Barter's median patient age at 59, with 98% women.

In 2024, Dr. Barter wrote 51 Medicare Part D claims for 19 patients. 96% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Barter for performance year 2024, reported as part of a group.

Dmand AI links 46 papers to Dr. Barter, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Uterine Neoplasms, Ovarian Neoplasms and Antineoplastic Agents. Dr. Barter has published most often in Gynecol Oncol. Dr. Barter's most frequent co-authors are James W. Orr, MD, Robert L. Coleman, MD and Edward C. Grendys, MD.

Dmand AI links Dr. Barter to 7 clinical trials, 4 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Ovarian Epithelial, Ovarian Neoplasms and Fallopian Tube Diseases. Tesaro, Inc. sponsors the most, 2.

CMS Open Payments shows 98 general payments to Dr. Barter from 15 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 52% of the total. Baxter Healthcare paid the most, $38,412.

Dmand AI lists 16 awards for Dr. Barter, most recently America�s Top Doctors in 2019.

Dr. Barter graduated from UVA School of Medicine in 1977. Dr. Barter is a member of American College of Obstetricians and Gynecologists.

Dr. Barter is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.